Extracellular Vesicles and Circulating Nucleic Acids

Extracellular Vesicles and Circulating Nucleic Acids is an open access peer-reviewed journal published by OAE Publishing Inc. since 2021 under the eISSN 2767-6641, covering extracellular vesicles and circulating nucleic acids with a 2025 Journal Impact Factor of 8.5 and first quartile ranks of 36 of 328 in biochemistry and molecular biology and 35 of 207 in cell biology in the Emerging Sources Citation Index《细胞外囊泡与循环核酸》（Extracellular Vesicles and Circulating Nucleic Acids）是（OAE Publishing Inc.）自 2021 年起出版的开放获取同行评审期刊，电子刊号 2767-6641，覆盖细胞外囊泡与循环核酸，2025 年影响因子为 8.5，在（ESCI）生物化学与分子生物学类 328 种期刊中列第 36 位、在细胞生物学类 207 种期刊中列第 35 位，均居第一四分位。

Scope

• The journal publishes original research, reviews and perspectives on extracellular vesicles and circulating nucleic acids, including biogenesis, characterization, biomarker discovery, liquid biopsy and therapeutic applications该刊刊载细胞外囊泡与循环核酸领域的原创研究、综述与观点，涉及生物发生、表征、生物标志物发现、液体活检与治疗应用等方向。
• It gives particular attention to translational studies that advance vesicle and nucleic acid research toward clinical diagnostics, and it welcomes interdisciplinary work linking cell biology with clinical oncology and molecular diagnostics该刊特别关注将囊泡与核酸研究推向临床诊断的转化研究，并欢迎细胞生物学与临床肿瘤学及分子诊断交叉的研究。
• Article types include research articles, reviews, short communications, methods and protocols, and the journal operates a continuous publication model with articles assigned to a single annual volume文章类型包括研究论文、综述、短通讯、方法与方案，该刊采用连续出版模式，文章归入单一年度卷。
• As an open access journal it applies a Creative Commons attribution licence to accepted articles and levies an article processing charge on the corresponding author, with waivers available for qualifying authors作为开放获取期刊，该刊对录用文章采用知识共享署名许可，向通讯作者收取文章处理费，并对符合条件的作者提供减免。
• Peer review is conducted single-blind and the journal follows the publisher editorial policies on data availability, research integrity and competing interests同行评审采用单盲方式，该刊遵循出版方关于数据可获取性、研究诚信与利益冲突的编辑政策。
• The journal is abstracted and indexed in the Emerging Sources Citation Index, Scopus, PubMed Central and the Directory of Open Access Journals, and it is included in the Journal Citation Reports from the 2022 edition onwards该刊被（Emerging Sources Citation Index）、（Scopus）、（PubMed Central）与开放获取期刊目录收录，并自 2022 年版起纳入期刊引证报告。

History

• The journal was launched in 2021 by OAE Publishing Inc. to serve the growing community of extracellular vesicle and liquid biopsy researchers, and its founding editorial board drew members from leading vesicle research laboratories worldwide该刊于 2021 年由（OAE Publishing Inc.）创办，服务于日益壮大的细胞外囊泡与液体活检研究者群体，首届编委来自世界各地领先的囊泡研究实验室。
• It was conceived as a dedicated venue for research on both extracellular vesicles and circulating nucleic acids, two complementary pillars of liquid biopsy, and it has published work spanning basic biology to clinical validation该刊定位为细胞外囊泡与循环核酸两大液体活检支柱的专门发表平台，刊文涵盖从基础生物学到临床验证。
• From its first year the journal operated as a gold open access title with a Creative Commons licence, and it has retained the continuous publication model since launch自创刊起该刊即为金色开放获取期刊，采用知识共享许可，并一直沿用连续出版模式。
• The Journal Impact Factor was first reported as 4.8 in 2024 and rose to 8.5 in 2025, placing the journal in the first quartile of both biochemistry and molecular biology and cell biology该刊的影响因子在 2024 年版首报 4.8，2025 年版升至 8.5，居生物化学与分子生物学及细胞生物学两类第一四分位。
• The publisher carries the journal on its own platform and the digital object identifier prefix of its articles is 10.20517, assigned to OAE Publishing titles出版方将该刊载于自有平台，其文章的数字对象唯一标识符前缀为（10.20517），为（OAE Publishing）期刊专用前缀。

Editors

• The journal is led by an editor-in-chief supported by an international editorial board whose members are drawn from vesicle research centres, molecular biology departments and clinical laboratories across the world该刊由一位主编带领，配以由世界各地囊泡研究中心、分子生物学系与临床实验室学者组成的国际编委会。
• The editorial board includes section editors responsible for subject areas such as vesicle biogenesis, vesicle characterization, circulating DNA and liquid biopsy, reflecting the scope of the journal编委会设有学科编辑，分别负责囊泡生物发生、囊泡表征、循环（DNA）与液体活检等方向，对应刊物的定位。
• Editorial handling follows the editorial management system of the publisher, with submissions assigned to handling editors based on subject expertise and competing interest declarations稿件处理依托出版方的编辑管理系统，依据学科专长与利益冲突声明分配责任编辑。
• Peer review is conducted single-blind and the journal maintains the publisher standards on reviewer recruitment, conflict of interest management, data sharing and editorial independence同行评审采用单盲方式，该刊遵循出版方在审稿人遴选、利益冲突管理、数据共享与编辑独立性方面的标准。
• The masthead and board roster are published on the journal page at the publisher website and updated as new members join or existing members step down编委名单在出版方网站期刊页公布，并随成员增减而更新。